Janakiraman Subramanian

9PUBLICATIONS
19CO-AUTHORS
Cancer geneticsPredictive and prognostic markersToxicology (incl. clinical toxicology)Molecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 25, 2026
Molecular Tumor Board-Directed Treatment for Patients with Advanced-Stage Solid Tumors: A Case-Control Real-World Study.

|May 06, 2026
Immunotherapy Response and Survival Outcome by Immunophenotypic Signature in Non-Small Cell Lung Cancer.

|Dec 21, 2022
A review of therapeutic failures in late-stage clinical trials.

Ritu Jain, Janakiraman Subramanian, Anurag S Rathore

|Jan 17, 2022
Squamous cell carcinoma of the lung: improving the detection and management of immune-related adverse events.

Lara Kujtan, Rama Krishna Kancha, Beth Gustafson

|May 07, 2021
Detection of MET exon 14 skipping mutations in non-small cell lung cancer: overview and community perspective.

Janakiraman Subramanian, Ossama Tawfik

|Jul 12, 2019
Emergence of ERBB2 Mutation as a Biomarker and an Actionable Target in Solid Cancers.

Janakiraman Subramanian, Archana Katta, Ashiq Masood

Pageof 2

Frequent Collaborators

2 joint publications

Lara Kujtan

2 joint publications

Christopher Ward

1 joint publications

Anurag S Rathore

1 joint publications

Dhruv Bansal